Table. Baseline Characteristics of African American and White Patients Undergoing Lung Cancer Screening.
| Characteristics | Patients, No. (%) | P value | |
|---|---|---|---|
| 1276 Patients in full sample | African American (n = 545) | White (n = 731) | |
| Age, mean (SD), y | 64.09 (5.70) | 64.37 (5.89) | .40 |
| Gender | |||
| Female | 343 (62.9) | 414 (56.6) | .02 |
| Male | 202 (37.1) | 317 (43.4) | |
| Ethnicity | |||
| Hispanic/Latinx | 1 (0.2) | 48 (6.6) | <.001 |
| Smoking status | |||
| Current | 348 (63.9) | 358 (49.0) | <.001 |
| Former | 197 (36.1) | 373 (51.0) | |
| Pack-years, mean (SD), y | 48.71 (20.56) | 57.95 (27.51) | <.001 |
| Cigarettes, mean (SD) | 21.62 (8.45) | 25.89 (11.79) | <.001 |
| Smoking duration, mean (SD), y | 45.25 (7.15) | 44.81 (8.18) | .304 |
| Time since quitting, mean (SD), y | 5.16 (4.97) | 6.69 (5.45) | .001 |
| Time smoked, mean (SD), y | 45.25 (7.15) | 44.81 (8.18) | .30 |
| Personal history of cancer | 83 (15.6) | 161 (22.6) | .002 |
| Family history of lung cancer | 123 (22.6) | 167 (22.8) | .91 |
| COPD | 241 (44.2) | 292 (39.9) | .13 |
| Body mass index, mean (SD)a | 30.01 (7.27) | 29.11 (6.42) | .02 |
| Education | |||
| Less than high school diploma | 77 (14.1) | 85 (11.6) | <.001 |
| High school graduate | 243 (44.6) | 287 (39.3) | |
| Post high school training | 19 (3.5) | 28 (3.8) | |
| Some college | 113 (20.7) | 119 (16.3) | |
| College graduate | 37 (6.8) | 98 (13.4) | |
| Post graduate/professional degree | 19 (3.5) | 60 (8.2) | |
| Unknown | 37 (6.8) | 54 (7.4) | |
| Insurance status | |||
| Medicare only | 174 (31.9) | 240 (32.8) | <.001 |
| Medicaid/dual eligible | 192 (35.2) | 134 (18.3) | |
| Private only | 138 (25.3) | 243 (33.2) | |
| Medicare with supplement | 26 (4.8) | 69 (9.4) | |
| Private with supplement | 10 (1.8) | 24 (3.3) | |
| Other/none | 5 (0.9) | 21 (2.9) | |
| 32 Patients with screen-detected lung cancer | |||
| Characteristics | African American (n = 14) | White (n = 18) | |
| Age, mean (SD) | 64.86 (5.60) | 66.44 (5.87) | NA |
| Gender | |||
| Female | 12 (85.7) | 11 (61.1) | NA |
| Male | 2 (14.3) | 7 (38.9) | NA |
| Histology | NA | ||
| Adenocarcinoma | 11 (78.6) | 10 (55.6) | NA |
| Squamous cell carcinoma | 1 (7.1) | 3 (16.7) | NA |
| Small cell carcinoma | 0 (0.0) | 3 (16.7) | NA |
| Neuroendocrine carcinoma | 0 (0.0) | 1 (5.6) | NA |
| Non-small cell carcinoma | 2 (14.3) | 1 (5.6) | NA |
| Stage | |||
| I | 10 (71.4) | 9 (50.0) | NA |
| II | 1 (7.1) | 0 (0.0) | NA |
| III | 2 (14.3) | 4 (22.2) | NA |
| IV | 1 (7.1) | 2 (11.1) | NA |
| Limited stage small cell | 0 | 1 (5.6) | NA |
| Extensive stage small cell | 0 | 2 (11.1) | NA |
Abbreviation: COPD, chronic obstructive pulmonary disease.
a
Body mass index is calculated as weight in kilograms divided by height in meters squared.